Logo image of NTS.CA

Nanotech Security Corp (NTS.CA) Stock Fundamental Analysis

TSX-V:NTS - TSX Venture Exchange -

1.25  +0.02 (+1.63%)

Fundamental Rating

3

Overall NTS gets a fundamental rating of 3 out of 10. We evaluated NTS against 12 industry peers in the Aerospace & Defense industry. NTS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NTS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NTS had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -5.37%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -10.66%
PM (TTM) -15.84%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

NTS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

There is no outstanding debt for NTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 4.92 indicates that NTS has no problem at all paying its short term obligations.
A Quick Ratio of 4.78 indicates that NTS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.92
Quick Ratio 4.78

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.00% over the past year.
The Revenue has grown by 59.14% in the past year. This is a very strong growth!
Measured over the past years, NTS shows a quite strong growth in Revenue. The Revenue has been growing by 8.41% on average per year.
EPS 1Y (TTM)32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.69%
Revenue 1Y (TTM)59.14%
Revenue growth 3Y1.65%
Revenue growth 5Y8.41%
Sales Q2Q%33.82%

3.2 Future

Based on estimates for the next years, NTS will show a very negative growth in Earnings Per Share. The EPS will decrease by -65.14% on average per year.
The Revenue is expected to grow by 12.69% on average over the next years. This is quite good.
EPS Next Y106.9%
EPS Next 2Y-139.45%
EPS Next 3Y-95.2%
EPS Next 5Y-65.14%
Revenue Next Year-5.19%
Revenue Next 2Y8.88%
Revenue Next 3Y11.13%
Revenue Next 5Y12.69%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NTS.CA Yearly Revenue VS EstimatesNTS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NTS.CA Yearly EPS VS EstimatesNTS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -0.05 -0.1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NTS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTS.CA Price Earnings VS Forward Price EarningsNTS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 441.53
NTS.CA Per share dataNTS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

A cheap valuation may be justified as NTS's earnings are expected to decrease with -95.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-139.45%
EPS Next 3Y-95.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Nanotech Security Corp

TSX-V:NTS (10/4/2021, 7:00:00 PM)

1.25

+0.02 (+1.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.71%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap86.75M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.61
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 441.53
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.13
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -10.66%
PM (TTM) -15.84%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.92
Quick Ratio 4.78
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.69%
EPS Next Y106.9%
EPS Next 2Y-139.45%
EPS Next 3Y-95.2%
EPS Next 5Y-65.14%
Revenue 1Y (TTM)59.14%
Revenue growth 3Y1.65%
Revenue growth 5Y8.41%
Sales Q2Q%33.82%
Revenue Next Year-5.19%
Revenue Next 2Y8.88%
Revenue Next 3Y11.13%
Revenue Next 5Y12.69%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A